Lubiprostone - HY-B0679
Nur noch %1 verfügbar
Catalog #
HY-B0679
Ab
62,00 €
Lubiprostone (SPI-0211) increases intestinal fluid secretion through generation of CIC-2/CFTR and activation of cAMP signaling pathway. Lubiprostone inhibits myeloperoxidase (MPO) activity, downregulates Indomethacin (HY-14397)-induced iNOS and TNFα expression. Lubiprostone can be used for chronic constipation research[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0679/Lubiprostone-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Metabolism-sugar/lipid metabolism |
| Alternative Names | RU-0211; SPI-0211 |
| CAS | 136790-76-6 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 390.46 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | CFTR;Chloride Channel;Glutathione Peroxidase;NO Synthase;TNF Receptor |
| Application: | Metabolism-sugar/lipid metabolism |
|---|